Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 1, 2020, Pages

  Ohlsson, Arne ^a   Shah, Sachin S ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Surya Hospital for Women and Children   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INDOMETACIN; ENZYME INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTERVENTION STUDY; LOW BIRTH WEIGHT; NEWBORN MORTALITY; NUMBER NEEDED TO TREAT TO BENEFIT; NUMBER NEEDED TO TREAT TO HARM; NUMBERS NEEDED TO TREAT; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; ADVERSE DRUG REACTION; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CEREBRAL HEMORRHAGE; CYCLOOXYGENASE INHIBITORS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; DUCTUS ARTERIOSUS, PATENT; ENTEROCOLITIS, NECROTIZING; ENZYME INHIBITORS; GASTROINTESTINAL HEMORRHAGE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85078331048     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004213.pub5     Document Type: Review

References (63)

1. Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V, et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatrica 2000;89(11):1369-74. [PUBMED: 11106052]x-wiley/crsRef/11497645
2. Rubaltelli FF, Bertini G, Reali MF, Vangi V, Dani C. Does early closure of PDA with ibuprofen reduce the severity of RDS in premature infants?. Pediatric Research 1998;43:296. [DOI: 10.1203/00006450-199804001-01758]x-wiley/crsRef/11497646
3. Dani C, Bertini G, Pezati M, Poggi C, Guerrini P, Martano C, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005;115(6):1529-35. [DOI: 10.1542/peds.2004-1178; PUBMED: 15930213]x-wiley/crsRef/11497647
4. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. European Journal of Pediatrics 2000;159(5):364-8. [PUBMED: 10834523]x-wiley/crsRef/11497648
5. Gournay V, Roze JC, Daoud P, Cambonie G, Hascoet JM, Chamboux C, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364(9449):1939-44. [DOI: 10.1016/S0140-6736(04)17476-X; PUBMED: 15567009]x-wiley/crsRef/11497649
6. Gournay V, Savagner C, Thirez G, Kuster A, Roze JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359(9449):1486-8. [DOI: 10.1016/S0140-6736(04)17476-X; PUBMED: 15567009]x-wiley/crsRef/11497650
7. Kalani M, Shariat M, Khalesi N, Farahani Z, Ahmadi S. A comparison of early ibuprofen and indomethacin administration to prevent intraventricular hemorrhage among preterm infants. Acta Medica Iranica 2016;54(12):788-92. [PUBMED: 28120591]x-wiley/crsRef/11497652
8. Kanmaz G, Erdeve O, Canpolat FE, Oğuz SS, Uras N, Altug N, et al. Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus. European Journal of Clinical Pharmacology 2013;69(5):1075-81. [DOI: 10.1007/s00228-012-1438-8; PUBMED: 23128963]x-wiley/crsRef/11497654
9. Sangtawesin V, Sangtawesin C, Raksasinborisut C, Sathirakul K, Kanjanapattanakul W, Khorana M, et al. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. Journal of the Medical Association of Thailand 2006;89(3):314-20. [PUBMED: 16696414]x-wiley/crsRef/11497655
10. Sangtawesin C, Sangtawesin V, Lertsutthiwong W, Kanjanapattanakul W, Khorana M, Ayudhaya JK. Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants. Journal of the Medical Association of Thailand 2008;91:S28-34. [PUBMED: 19255990]x-wiley/crsRef/11497656
11. Naulaers G, Delanghe G, Allegaert K, Debeer A, Cossey V, Vanhole C, et al. Ibuprofen and cerebral oxygenation and circulation. Archives of Disease in Childhood Fetal Neonatal Edition 2005;90(1):F75-6. [DOI: 10.1136/adc.2004.058347; PUBMED: 15613583]x-wiley/crsRef/11497657
12. Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwe W, Jespers A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004;364(9449):1945-9. [DOI: 10.1016/S0140-6736(04)17477-1; PUBMED: 15567010]x-wiley/crsRef/11497658
13. Van Overmeire B, Casaer A, Allegaert K, Debauche C, Decaluwe W, Jespers A. Multicenter ibuprofen prophylaxis study (MIPS) in preterm infants: preliminary data. Pediatric Research 2002;52:825. x-wiley/crsRef/11497659
14. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent ductus arteriosus in premature newborn infants. Journal of the American Medical Association 1996;275(7):539-44. [PUBMED: 8606475]x-wiley/crsRef/11497660
15. Bell MJ, Ternberg KL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotising enterocolitis: therapeutic decisions based on clinical staging. Annals of Surgery 1978;187(1):1-7. [PUBMED: 413500]
16. Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981;68(1):99-102. [PUBMED: 6909683]
17. Chemtob S, Beharry K, Barna T, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990;21(5):777-84. [PUBMED: 2339458]
18. Chemtob S, Roy MS, Abran D, Fernandez H, Varma DR. Prevention of post asphyxial increase in lipid peroxides and retinal function and deterioration in the newborn pig by inhibition of cyclooxygenase activity and free radical generation. Pediatric Research 1993;33(4 Pt 1):336-40. [DOI: 10.1203/00006450-199304000-00006; PUBMED: 8479812]
19. Clyman RI. Ibuprofen and patent ductus arteriosus. New England Journal of Medicine 2000;343(10):728-30. [DOI: 10.1056/NEJM200009073431009; PUBMED: 10974138]
20. Coceani F, White E, Bodach E, Olley PM. Age dependent changes in the response of lamb ductus arteriosus to oxygen and ibuprofen. Canadian Journal of Physiology and Pharmacology 1979;57(8):825-31. [PUBMED: 497895]
21. Coceani F, Barogi S, Brizzi F, Ackerley C, Seidlitz E, Kelsey L, et al. Cyclooxygenase isoenzymes and patency of ductus arteriosus. Prostaglandins, Leukotrienes and Essential Fatty Acids 2005;72(2):71-7. [DOI: 10.1016/j.plefa.2004.10.004; PUBMED: 15626588]
22. Cotton RB, Stahlman MT, Kovar I, Catterton WZ. Medical management of small preterm infants with symptomatic patent ductus arteriosus. Journal of Pediatrics 1978;2(3):467-73. [PUBMED: 632994]
23. Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, Hoekstra RE, et al. Prophylactic Indomethacin therapy in the first twenty four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. Journal of Pediatrics 1996;128(5 Pt 1):631-7. [PUBMED: 8627434]
24. Davis P, Turner-Gomes S, Cunningham K, Way C, Roberts R, Schmidt B. Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus. Archives of Pediatric and Adolescent Medicine 1995;149(10):1136-41. [PUBMED: 7550818]
25. Di Micco S, Terracciano S, Cantone V, Fischer K, Koeberle A, Foglia A, et al. Discovery of new potent molecular entities able to inhibit mPGES-1. European Journal of Medicinal Chemistry 2018;143:1419-27. [DOI: 10.1016/j.ejmech.2017.10.039; PUBMED: 29133047]
26. Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF. Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant treated < 1250g. Pediatric Research 1994;35:331A.
27. Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delply DT, et al. Effects of indomethacin on cerebral hemodynamics in very preterm infants. Lancet 1990;335(8704):1491-5. [PUBMED: 1972434]
28. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD000174]
29. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacological closure of patent ductus arteriosus in the premature infant. New England Journal of Medicine 1976;295(10):526-9. [DOI: 10.1056/NEJM197609022951003frie; PUBMED: 820994]
30. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of Indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. Journal of Pediatrics 1983;102(6):895-906. [PUBMED: 6343572]
31. Grosfeld JL, Chaedt M, Molinari F, Engle W, Engum SA, West KW, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Annals of Surgery 1996;224(3):350-7. [PUBMED: 8813263]
32. Hammerman C. Patent ductus arteriosus: clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clinics in Perinatology 1995;22(2):457-79. [PUBMED: 7671547]
33. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327(7414):557-60. [DOI: 10.1136/bmj.327.7414.557; PUBMED: 12958120]
34. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook.
35. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Archives of Ophthalmology 1984;102(8):1130-4. [PUBMED: 6547831]
36. Ito K, Niida Y, Sato J, Owada E, Ito K, Umetsu M. Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus. Acta Paediatrica Japonica 1994;36(4):387-91. [PUBMED: 7942001]
37. Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I. Network meta-analysis of indomethacin versus placebo for PDA in preterm infants. Archives of Disease in Childhood Neonatal Edition 2011;96(1):F45-52. [DOI: 10.1136/adc.2009.168682; PUBMED: 20876595]
38. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. European Journal of Pediatrics 2002;161(4):202-7. [PUBMED: 12014386]
39. Lee Sk, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, et al. Variations in practice and outcomes in the Canadian NICU network: 1996-1997. Pediatrics 2000;106(5):1070-9. [PUBMED: 11061777]
40. Mosca F, Bray M, Lattnazio M, Fumagalli M, Toscetto C. Comparative evaluation of the effect of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1997;131(4):549-54. [PUBMED: 9386657]
41. Mosca F, Bray M, Stucchi I, Fumagalli M. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;9338:1023-4.
42. Niopas I, Mamzoridi K. Determination of indomethacin and mefenamic acid in plasma performance liquid chromatography. Journal of Chromatography. Biomedical Applications 1994;656(2):447-50. [PUBMED: 7987501]
43. Ohlsson A, Bottu J, Govan J, Ryan ML, Fong K, Myhr T. The effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with patent ductus arteriosus. Developmental Pharmacology and Therapeutics 1993;20(1-2):100-6. [PUBMED: 7924757]
44. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2018, Issue 9. [DOI: 10.1002/14651858.CD003481.pub7]
45. Pai VB, Sakadjian A, Puthoff TD. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus. Pharmacotherapy 2008;28(9):1162-82. [DOI: 10.1592/phco.28.9.1162; PUBMED: 18752387]
46. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1,500 grams. Journal of Pediatrics 1978;92(4):529-34. [PUBMED: 305471]
47. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomised double blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatric Research 2000;47(1):36-42. [PUBMED: 10625080]
48. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. Journal of Pediatrics 1999;135(6):733-8. [PUBMED: 10586177]
49. Ramanathan R, Siassi B, Gallagher R, DeLemos RA. Outcome of very low birth weight infants < 1500 g enrolled in the national database network: are there any trends in neonatology?. Pediatric Research 1997;41:171A.
50. Sakhalkar VS, Merchant RH. Therapy of patent ductus arteriosus in preterms with mefenamic acid and indomethacin. Indian Pediatrics 1992;29(3):313-8. [PUBMED: 1612672]
51. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts R, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. New England Journal of Medicine 2001;344(26):1966-72. [DOI: 10.1056/NEJM200106283442602; PUBMED: 11430325]
52. Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
53. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82(4):527-32. [PUBMED: 3174313]
54. Speziale MV, Allen RG, Henderson CR, Barrington KJ, Finer NN. Effects of ibuprofen and indomethacin on the regional circulation in newborn piglets. Biology of the Neonate 1999;76(4):242-52. [DOI: 10.1159/000014165; PUBMED: 10473899]
55. Van Bel F, Van de Bor M, Stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics 1989;84(5):802-7. [PUBMED: 2677960]
56. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Archives of Disease in Childhood. Fetal and Neonatal Edition 1997;76(3):F179-84. [PUBMED: 9175948]
57. Van Overmeire B, Smets K, Lecoutere D, Van De Broek H, Weyler J, De Groote K, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. New England Journal of Medicine 2000;334:674-81.
58. Wyllie JP, Gupta S. Prophylactic and early targeted treatment of patent ductus arteriosus. Seminars in Fetal and Neonatal Medicine 2018;23(4):250–4. [DOI: 10.1016/j.siny.2018.03.005; PUBMED: 29571706]
59. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2009, Issue 1.
60. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD004213.pub3]
61. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
62. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD004213]
63. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2006, Issue 1.